PMID- 29075136
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20200930
IS  - 1178-7090 (Print)
IS  - 1178-7090 (Electronic)
IS  - 1178-7090 (Linking)
VI  - 10
DP  - 2017
TI  - Outcomes of C1-2 joint injections.
PG  - 2263-2269
LID - 10.2147/JPR.S144255 [doi]
AB  - OBJECTIVE: Intra-articular injections of the C1-2 joint are an effective 
      therapeutic option for pain generated from degenerative and inflammatory 
      conditions affecting the joint. Limited information exists about the adverse 
      events (AEs) associated with these injections. The primary aim of this study is 
      to describe the frequency and type of AEs associated with C1-2 joint injections. 
      The secondary aim is to identify clinical factors associated with the occurrence 
      of AEs of C1-2 joint injections. DESIGN/METHODS: A retrospective chart review was 
      conducted on all C1-2 joint injections performed at the Mayo Pain Medicine Clinic 
      in Rochester, MN, from January 1, 2005 through July 31, 2015. AE data were 
      extracted from procedural and post-procedural clinical notes. Analysis was 
      conducted to determine correlations between any AE and demographic and clinical 
      characteristics. Using univariate and multivariate logistic regression analyses, 
      associations were determined. RESULTS: From January 1, 2005 to July 31, 2015, 135 
      C1-2 injections were performed on 72 patients. Overall, at least 1 AE was 
      reported in 18.5% of the injections. The most common AEs were post-procedural 
      increase in pain and procedural vascular contrast uptake. There was a significant 
      association between AE occurrence and greater pre-procedural maximum pain score. 
      CONCLUSIONS: AEs from C1-2 joint injections occurred commonly, but there were no 
      persistent or serious AEs associated with these injections. The data also 
      demonstrate that patients with higher pre-procedural maximum pain scores are more 
      likely to experience an AE.
FAU - Aiudi, Christopher M
AU  - Aiudi CM
AD  - Mayo Clinic School of Medicine.
FAU - Hooten, W Michael
AU  - Hooten WM
AD  - Division of Pain Medicine, Department of Anesthesia and Perioperative Medicine, 
      Mayo Clinic.
FAU - Sanders, Rebecca A
AU  - Sanders RA
AD  - Division of Pain Medicine, Department of Anesthesia and Perioperative Medicine, 
      Mayo Clinic.
FAU - Watson, James C
AU  - Watson JC
AD  - Division of Pain Medicine, Department of Anesthesia and Perioperative Medicine, 
      Mayo Clinic.
FAU - Moeschler, Susan M
AU  - Moeschler SM
AD  - Division of Pain Medicine, Department of Anesthesia and Perioperative Medicine, 
      Mayo Clinic.
FAU - Gazelka, Halena M
AU  - Gazelka HM
AD  - Division of Pain Medicine, Department of Anesthesia and Perioperative Medicine, 
      Mayo Clinic.
FAU - Hoelzer, Bryan C
AU  - Hoelzer BC
AD  - Division of Pain Medicine, Department of Anesthesia and Perioperative Medicine, 
      Mayo Clinic.
FAU - Eldrige, Jason S
AU  - Eldrige JS
AD  - Division of Pain Medicine, Department of Anesthesia and Perioperative Medicine, 
      Mayo Clinic.
FAU - Qu, Wenchun
AU  - Qu W
AD  - Department of Physical Medicine and Rehabilitation, Mayo Clinic, Rochester, MN, 
      USA.
FAU - Lamer, Tim J
AU  - Lamer TJ
AD  - Division of Pain Medicine, Department of Anesthesia and Perioperative Medicine, 
      Mayo Clinic.
LA  - eng
PT  - Journal Article
DEP - 20170918
PL  - New Zealand
TA  - J Pain Res
JT  - Journal of pain research
JID - 101540514
PMC - PMC5609790
OTO - NOTNLM
OT  - C1-2 joint
OT  - adverse event
OT  - facet
OT  - injection
COIS- Disclosure The authors report no conflicts of interest in this work.
EDAT- 2017/10/28 06:00
MHDA- 2017/10/28 06:01
PMCR- 2017/09/18
CRDT- 2017/10/28 06:00
PHST- 2017/10/28 06:00 [entrez]
PHST- 2017/10/28 06:00 [pubmed]
PHST- 2017/10/28 06:01 [medline]
PHST- 2017/09/18 00:00 [pmc-release]
AID - jpr-10-2263 [pii]
AID - 10.2147/JPR.S144255 [doi]
PST - epublish
SO  - J Pain Res. 2017 Sep 18;10:2263-2269. doi: 10.2147/JPR.S144255. eCollection 2017.